Neurologic Complications of HIV Infection

Topics in Antiviral Medicine

Volumn 20, Issue 2, 2012, Pages 41-47

  Spudich, Serena S ^a   Ances, Beau M ^b  

^a YALE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METHODOLOGY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PATHOGENICITY; PATHOLOGY; REVIEW; VIROLOGY;

AIDS DEMENTIA COMPLEX; ANTI-RETROVIRAL AGENTS; HIV-1; HUMANS; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS;

EID: 84867879409     PISSN: 21615861     EISSN: 21615853     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Centers for Disease Control and Prevention (CDC). Reported CD4+ T-Lymphocyte Results for Adults and Adolescents with HIV Infection-37 States, 2005-2007. http://www.cdc.gov/hiv/surveillance/resources/ reports/2010supp_vol16no1/index. htm. Accessed May 4, 2012.
2. Carey CL, Woods SP, Gonzalez R, et al. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26:307-319.
3. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789-1799.
4. Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24:1243-1250.
5. Heaton RK, Clifford DB, Franklin DR, Jr., et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75:2087-2096.
6. Becker JT, Kingsley L, Mullen J, et al. Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology. 2009;73:1292-1299.
7. Robertson KR, Smurzynski M, Parsons TD, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007;21:1915-1921.